Merck
Alexandra Snyder currently serves as Senior Vice President and Head of Translational Medicine & Discovery Oncology at Merck since July 2025. In addition, Alexandra holds a position as Voluntary Clinical Faculty at NYU and Bellevue since October 2019. Previously, Alexandra was Executive Vice President and Head of R&D at Generate Biomedicines from July 2022 to July 2025, also serving as Chief Medical Officer during that period and assuming the role of Head of R&D in June 2023. Alexandra has provided consulting services at Two River from August 2021 to July 2025 and served as a Board Member at Navigating Cancer from July 2022 to July 2024. Alexandra earned a Doctor of Medicine degree from the Icahn School of Medicine at Mount Sinai between January 2004 and January 2009.
This person is not in any teams
This person is not in any offices